Skip to content

Clinical trials

Completed Osteoporosis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Status: Completed Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20071
20082
20111
20122
20171
20181
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kowloon Hospital, Hong Kong2
Prince of Wales Hospital, Shatin, Hong Kong2
Radius Health, Inc.2
Amgen1
Chinese University of Hong Kong1
Eli Lilly and Company1
Ligand Pharmaceuticals1
Nordic Bioscience A/S1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis13
Bone Diseases, Metabolic4
Osteoporosis, Postmenopausal4
Fractures, Bone2
Sarcopenia2
Bone Diseases1
Hip Fractures1
Liver Cirrhosis1
Metabolic Syndrome1
Musculoskeletal Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.